Detalhe da pesquisa
1.
An Official American Thoracic Society Research Statement: Implementation Science in Pulmonary, Critical Care, and Sleep Medicine.
Am J Respir Crit Care Med
; 194(8): 1015-1025, 2016 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27739895
2.
Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib.
Mol Cell Biol
; 26(16): 6082-93, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16880519
3.
Patient and Clinician Characteristics Associated with Adherence. A Cohort Study of Veterans with Incidental Pulmonary Nodules.
Ann Am Thorac Soc
; 13(5): 651-9, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27144794
4.
Intensive care unit scoring systems outperform emergency department scoring systems for mortality prediction in critically ill patients: a prospective cohort study.
J Intensive Care
; 2: 40, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25960880
5.
In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl-positive cell lines.
Blood
; 103(1): 208-15, 2004 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12933582
6.
Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML.
Blood
; 104(8): 2532-9, 2004 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15256422